Coordination, cooperation, and creativity within harm reduction networks in Iran: COVID-19 prevention and control among people who use drugs

被引:11
作者
Alavi, Maryam [1 ,2 ]
Moghanibashi-Mansourieh, Amir [3 ]
Radfar, Seyed Ramin [4 ]
Alizadeh, Sepideh [5 ]
Bahramabadian, Fatemeh [6 ]
Esmizade, Sara [7 ]
Dore, Gregory J. [1 ]
Sedeh, Farid Barati [8 ]
Deilamizade, Abbas [9 ]
机构
[1] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia
[2] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran
[3] Univ Social Welf & Rehabil Sci, Dept Social Work, Kodakyar Ave,Daneshjo Blvd, Tehran 1985713834, Iran
[4] Univ Social Welf & Rehabil Sci, Subst Abuse & Dependence Res Ctr, Tehran, Iran
[5] Noore Sepid Hedayat Harm Reduct Inst, Tehran, Iran
[6] Payam Avaran E Hamyari Chatra Nongovt Org, Tehran, Iran
[7] Univ Tehran, Fac Social Sci, Tehran, Iran
[8] State Welf Org, Ctr Prevent & Treatment Addict, Tehran, Iran
[9] Rebirth Char Soc, Tehran, Iran
关键词
Marginalised people; Vulnerable people; Pandemic; Homelessness; Public health; Civil society; ECONOMIC SANCTIONS; CAPACITY; HEALTH;
D O I
10.1016/j.drugpo.2020.102908
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
An unprecedented public health crisis confronts the world. Iran is among the hardest-hit countries, where effects of the COVID-19 pandemic are stretched across society and felt by the most marginalised people. Among people who use drugs, a comprehensive response to the crisis calls for broad collaboration, coordination, and creativity involving multiple government and non-government organisations. This commentary provides early insights into an unfolding experience, demonstrating the operational and policy impact of an initiative, bringing together a diverse array of harm reduction stakeholders to address the pandemic. In the context of lived experiences of social and economic marginalization, this initiative intends to lead efforts in developing an equitable response to the COVID-19 pandemic.
引用
收藏
页数:5
相关论文
共 28 条
[1]   Drug use treatment and harm reduction programs in Iran: A unique model of health in the most populated Persian Gulf country [J].
Alam-mehrjerdi, Zahra ;
Abdollahi, Mohammad ;
Higgs, Peter ;
Dolan, Kate .
ASIAN JOURNAL OF PSYCHIATRY, 2015, 16 :78-83
[2]   An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study [J].
Alavi, Maryam ;
Poustchi, Hossein ;
Merat, Shahin ;
Kaveh-ei, Soudeh ;
Rahimi-Movaghar, Afarin ;
Shadloo, Behrang ;
Hajarizadeh, Behzad ;
Grebely, Jason ;
Dore, Gregory J. ;
Malekzadeh, Reza .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2019, 72 :99-105
[3]   Connecting Society and Policymakers? Conceptualizing and Measuring the Capacity of Civil Society Organizations to Act as Transmission Belts [J].
Albareda, Adria .
VOLUNTAS, 2018, 29 (06) :1216-1232
[4]  
Ameli V, 2020, NEW LEFT REV, P49
[5]   The risk environments of people who use drugs accessing two harm reduction centers in Tehran, Iran: A qualitative study [J].
Bastani, Parsa ;
Marshall, Brandon D. L. ;
Rahimi-Movaghar, Afarin ;
Noroozi, Alireza .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2019, 63 :90-96
[6]   COVID-19: towards controlling of a pandemic [J].
Bedford, Juliet ;
Enria, Delia ;
Giesecke, Johan ;
Heymann, David L. ;
Ihekweazu, Chikwe ;
Kobinger, Gary ;
Lane, H. Clifford ;
Memish, Ziad ;
Oh, Myoung-don ;
Sall, Amadou Alpha ;
Schuchat, Anne ;
Ungchusak, Kumnuan ;
Wieler, Lothar H. .
LANCET, 2020, 395 (10229) :1015-1018
[7]  
Deilamizade A, 2020, PROPOSED PROTOCOL AR
[8]   The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity? [J].
Ekhtiari, Hamed ;
Noroozi, Alireza ;
Farhoudian, Ali ;
Radfar, Seyed Ramin ;
Hajebi, Ahmad ;
Sefatian, Saeed ;
Zare-bidoky, Mehran ;
Razaghi, Emran Mohammad ;
Mokri, Azarakhsh ;
Rahimi-Movaghar, Afarin ;
Rawson, Richard .
ADDICTION, 2020, 115 (07) :1395-1403
[9]  
Farhoudian A, 2020, IN PRESS, DOI [10.6084/m9. figshare.12033567.v9, DOI 10.6084/M9.FIGSHARE.12033567.V9]
[10]  
Ghiabi M, 2020, MIDDLE E RES INFORM